DSDenhard de Smit

Denhard de Smit

*This is an algorithmically generated author record based on publicly available information.

Denhard de Smit has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of a simple educational intervention in well-baby clinics on women’s knowledge about and intake of folic acid supplements in the periconceptional period: a controlled trial

    by Denhard J de Smit, Stephanie S Weinreich, Martina C Cornel

    Objective: To test the hypothesis that a concise intervention to promote the preconception use of folic acid (FA) supplements among mothers who visit a well-baby clinic (WBC) for the 6-month check-up of their youngest child is effective. Effectiveness was measured as intention to use or actual use of FA supplements before a next pregnancy among women who expected to be pregnant within 0–12 months.Design: Controlled intervention study with independent samples of intervention and control mothers. The intervention took place at the 6-month visit. A post-intervention measurement was done in the intervention group and a comparable measurement in the control group at the 11-month check-up visit.Setting: The intervention, verbal and in writing, was implemented in four Dutch WBC and given by the WBC physician to the mothers who visited the WBC.Subjects: All mothers visiting the WBC were eligible for inclusion, unless they were unable to complete a questionnaire. The intervention group consisted of 198 (68 %) mothers recruited from 291 6-month intervention visits and the control group of 215 (84 %) mothers recruited from 255 11-month normal visits.Results: In mothers who expected to be pregnant within 0–12 months, the proportion using or intending to use FA was 65 % in the intervention group (n49)v. 42 % in the control group (n43; difference 23 %, 95 % CI 4, 43 %,P<0·05).Conclusions: Health education intervention at the 6-month WBC visit is an effective means to promote the use of FA supplements or the intention to do so.


  • Open Access

    Prevention of congenital malformations and other adverse pregnancy outcomes with 4.0 mg of folic acid: community-based randomized clinical trial in Italy and the Netherlands

    by Renata Bortolus, Fenneke Blom, Francesca Filippini, Mireille Nm van Poppel, Emanuele Leoncini, Denhard J de Smit, Pier Paolo Benetollo, Martina C Cornel, Hermien Ek de Walle, Pierpaolo Mastroiacovo

    In 2010 a Cochrane review confirmed that folic acid (FA) supplementation prevents the first- and second-time occurrence of neural tube defects (NTDs). At present some evidence from observational studies supports the hypothesis that FA supplementation can reduce the risk of all congenital malformations (CMs) or the risk of a specific and selected group of them, namely cardiac defects and oral clefts. Furthermore, the effects on the prevention of prematurity, foetal growth retardation and pre-eclampsia are unclear. Although the most common recommendation is to take 0.4 mg/day, the problem of the most appropriate dose of FA is still open. The aim of this project is to assess the effect a higher dose of peri-conceptional FA supplementation on reducing the occurrence of all CMs. Other aims include the promotion of pre-conceptional counselling, comparing rates of selected CMs, miscarriage, pre-eclampsia, preterm birth, small for gestational age, abruptio placentae. This project is a joint effort by research groups in Italy and the Netherlands. Women of childbearing age, who intend to become pregnant within 12 months are eligible for the studies. Women are randomly assigned to receive 4 mg of FA (treatment in study) or 0.4 mg of FA (referent treatment) daily. Information on pregnancy outcomes are derived from women-and-physician information. We foresee to analyze the data considering all the adverse outcomes of pregnancy taken together in a global end point (e.g.: CMs, miscarriage, pre-eclampsia, preterm birth, small for gestational age). A total of about 1,000 pregnancies need to be evaluated to detect an absolute reduction of the frequency of 8%. Since the sample size needed for studying outcomes separately is large, this project also promotes an international prospective meta-analysis. The rationale of these randomized clinical trials (RCTs) is the hypothesis that a higher intake of FA is related to a higher risk reduction of NTDs, other CMs and other adverse pregnancy outcomes. Our hope is that these trials will act as catalysers, and lead to other large RCTs studying the effects of this supplementation on CMs and other infant and maternal outcomes. Italian trial: ClinicalTrials.gov Identifier: NCT01244347 . Dutch trial: Dutch Trial Register ID: NTR3161 .


  • Open Access

    Preconception care

    by Denhard de Smit, Arzu Uzuner

    The involvement of the primary care sector in promoting and delivering preconception care is still on a very low level; as the aim of the Conference is to build the bridges between primary and secondary/ tertiary health care. Therefore, the aim of the workshop is to establish a communication environment for promoting and delivering preconception care (PC) by the PC sector and to establish its linkages to the secondary and tertiary care. During the workshop, an International networking for the development of a position paper for the process of involving primary care will be facilitated. The content of the workshop is as follows:-Introduction of experts and their areas of expertise.-Presentation and outlines of the topic, preconception care-Group work: SWOT analysis of the topic; people will have the opportunity to share their experiences and their ideas.-"let's focus on the challenges" Presentation of the main problematic areas (evidence based)-Brain storming: What should be done to increase the involvement of primary care and to build the bridges between primary and secondary/tertiary care for the PC.-Development of a position paper; the ideas of the participants for subheadings and preparatory work.-Summary of the workshop.